Varian to market cancer therapy device in US:
This article was originally published in Clinica
Executive Summary
Varian Medical Systems has received marketing clearance from the FDA for its Millennium MLC-120 multileaf collimator, a beam-shaping device which concentrates the radiation energy on the tumour instead of the surrounding healthy tissue. It is suitable for small, irregularly shaped lesions which occur on the head or neck, according to the Palo Alto, California-based company.